Despite the recent success of immuno-oncology drugs, their use in fibrotic cancers (pancreatic, ovarian cancer) has been met with limited success. Recent research shows that Focal Adhesion Kinase (FAK) is significantly upregulated in these highly fibrotic tumours and therefore drugs targeting FAK ha...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2016 (10 years)
Address:
LEVEL 17, 350 QUEEN STREET; MELBOURNE, VICTORIA 3000, AU
LOW
spending power